Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers
NCT00240500
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
109
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
BIOLOGICAL:
Engerix™-B
Sponsor
GlaxoSmithKline